RESUMEN
The metacestode stage of the fox tapeworm Echinococcus multilocularis causes the severe zoonotic disease alveolar echinococcosis. New treatment options are urgently needed. Disulfiram and dithiocarbamates were previously shown to exhibit activity against the trematode Schistosoma mansoni. As both parasites belong to the platyhelminths, here we investigated whether these compounds were also active against E. multilocularis metacestode vesicles in vitro. We used an in vitro drug-screening cascade for the identification of novel compounds against E. multilocularis metacestode vesicles with disulfiram and 51 dithiocarbamates. Five compounds showed activity against E. multilocularis metacestode vesicles after five days of drug incubation in a damage marker release assay. Structure-activity relationship analyses revealed that a S-2-hydroxy-5-nitro benzyl moiety was necessary for anti-echinococcal activity, as derivatives without this group had no effect on E. multilocularis metacestode vesicles. The five active compounds were further tested for potential cytotoxicity in mammalian cells. For two compounds with low toxicity (Schl-32.315 and Schl-33.652), IC50 values in metacestode vesicles and IC50 values in germinal layer cells were calculated. The compounds were not highly active on isolated GL cells with IC50 values of 27.0 ± 4.2 µM for Schl-32.315 and 24.7 ± 11.5 µM for Schl-33.652, respectively. Against metacestode vesicles, Schl-32.315 was not very active either with an IC50 value of 41.6 ± 3.2 µM, while Schl-33.652 showed a low IC50 of 4.3 ± 1 µM and should be further investigated in the future for its activity against alveolar echinococcosis.
RESUMEN
A new methodology for the preparation of Co(I)-NHC (NHC = N-heterocyclic carbene) complexes, namely, [Co(PCNHCP)(CO)2][Co(CO)4] (1) and [Co(PCNHCP)(CO)2]BF4 (2), has been developed (PCNHCP = 1,3-bis(2-(diphenylphosphanyl)ethyl)-imidazol-2-ylidene). Both complexes can be straightforwardly prepared by direct reaction of their parent imidazolium salts with the Co(0) complex Co2(CO)8. Complex 1 efficiently catalyses the reductive amination of furfural and levulinic acid employing silanes as reducing agents under mild conditions. Furfural has been converted into a variety of secondary and tertiary amines employing dimethyl carbonate as the solvent, while levulinic acid has been converted into pyrrolidines under solventless conditions. Dehydrocoupling of the silane to give polysilanes has been observed to occur as a side reaction of the hydrosilylation process.
RESUMEN
The catalysts [Ir(COD)(κ3-P,C,P'-PCNHCP)]BF4 and [Ir(COD)(κ2-P,C-PCNHCO)]BF4 proved to be active in the solventless dehydrogenation of formic acid. The impact of various cosolvents on the activity was evaluated, showing an outstanding improvement of the catalytic performance of [Ir(COD)(κ2-P,C-PCNHCO)]BF4] in "green" organic carbonates: namely, dimethyl carbonate (DMC) and propylene carbonate (PC). The TOF1h value for [Ir(COD)(κ2-P,C-PCNHCO)]BF4 increases from 61 to 988 h-1 upon changing from solventless conditions to a 1/1 (v/v) DMC/HCOOH mixture. However, in the case of [Ir(COD)(PCNHCP)]BF4, only a marginal improvement from 156 to 172 h-1 was observed under analogous conditions. Stoichiometric experiments allowed the identification of various key reaction intermediates, providing valuable information on their reactivity. Experimental data and DFT calculations point to the formation of dinuclear species as the catalyst deactivation pathway, which is prevented in the presence of DMC and PC.